Evidence map›Paper›PMID 33882194›Full record

ArticleAdvanced healthcare materials2021

A Biphasic Osteovascular Biomimetic Scaffold for Rapid and Self-Sustained Endochondral Ossification.

Hwan D Kim, Xuechong Hong, Young-Hyeon An, Mihn Jeong Park, Do-Gyoon Kim, Arin K Greene, Bonnie L Padwa, Nathaniel S Hwang, Ruei-Zeng Lin, Juan M Melero-Martin

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Bone-Targeted Delivery of Cell-Penetrating-RUNX2 Fusion Protein in Osteoporosis Model.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. Article
  10. Human Endothelial Colony-Forming Cells.Cold Spring Harbor perspectives in medicine · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Hwan D KimDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Xuechong HongDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Young-Hyeon AnSchool of Chemical and Biological Engineering, BioMAX Institute, Institute of Chemical Processes, Institute of Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
Mihn Jeong ParkSchool of Chemical and Biological Engineering, BioMAX Institute, Institute of Chemical Processes, Institute of Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
Do-Gyoon KimDivision of Orthodontics, College of Dentistry, The Ohio State University, Columbus, OH, 43210, USA.
Arin K GreeneDepartment of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Bonnie L PadwaDepartment of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Nathaniel S HwangSchool of Chemical and Biological Engineering, BioMAX Institute, Institute of Chemical Processes, Institute of Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
Ruei-Zeng LinDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.ORCID 0000-0002-4689-8149
Boston Children's Hospital · USSeoul National University · KRKorea National University of Transportation · KRThe Ohio State University · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Enhancing endothelial cell engraftment via transplantation of exogenous mitochondriaR01HL152133 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Juan M Melero-Martin · 2021 to 2026
$3.1M
Vascular niche bioengineering for human bone regenerationR01AR069038 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2020
$1.9M
NCI NIH HHS P30 CA006516NHLBI NIH HHS R01 HL128452NHLBI NIH HHS R01 HL152133NIAMS NIH HHS R01 AR069038
6 · The paper itself

Abstract

Regeneration of large bones remains a challenge in surgery. Recent developmental engineering efforts aim to recapitulate endochondral ossification (EO), a critical step in bone formation. However, this process entails the condensation of mesenchymal stem cells (MSCs) into cartilaginous templates, which requires long-term cultures and is challenging to scale up. Here, a biomimetic scaffold is developed that allows rapid and self-sustained EO without initial hypertrophic chondrogenesis. The design comprises a porous chondroitin sulfate cryogel decorated with whitlockite calcium phosphate nanoparticles, and a soft hydrogel occupying the porous space. This composite scaffold enables human endothelial colony-forming cells (ECFCs) and MSCs to rapidly assemble into osteovascular niches in immunodeficient mice. These niches contain ECFC-lined blood vessels and perivascular MSCs that differentiate into RUNX2

Indexed as

OsteogenesisTissue EngineeringAnimalsBiomimeticsChondrogenesisMiceTissue Scaffoldsbone tissue engineeringdevelopmental engineeringendochondral ossificationossification centersosteovascular niches

Identifiers

PMID33882194
PMCPMC8273143
OpenAlexW3156628141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.